News Search Results
Jul 15, 2025, 07:00 ET Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
Learn more about Spear Bio and Bio-Techne About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific
More news about: Bio-Techne Corporation
Jul 14, 2025, 07:00 ET Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
therapy for patients with RDEB." About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jul 08, 2025, 10:30 ET $2.35 Billion by 2030: Why In Situ Hybridization Is Revolutionizing Molecular Diagnostics | MarketsandMarkets™
biology tools.Abbott (US): Dominant in ISH probes for oncology and cytogenetics under the VYSIS brand.Bio-Techne (US): RNAscope portfolio expansion to 70,000+ probes position it as a spatial transcriptomics leader.Thermo Fisher
More news about: MarketsandMarkets
Jul 01, 2025, 11:23 ET Global Market for Media, Sera, and Reagents in Biotechnology to Reach $9.3 Billion by 2029
North America holds the largest share of the market. Market leaders include: ATCCBDBIO-TECHNEBIOWESTCORNING INC.DANAHER CORP.FUJIFILM IRVINE SCIENTIFICLONZAMERCK KGAAMILTENYI BIOTECPROMOCELL
More news about: BCC Research LLC
Jun 30, 2025, 10:15 ET IVD Assay Development Market to Reach $9.15 Billion by 2032, Growing at a CAGR of 8.1% from 2025, Says Meticulous Research®
development market include Thermo Fisher Scientific Inc. (U.S.), Avioq, Inc. (U.S.), Creative Biolabs, Inc (U.S.), Maxim Biomedical, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), PeploBio Ltd (U.K.), ICON plc (Ireland),
More news about: Meticulous Market Research Pvt. Ltd.
Jun 24, 2025, 07:00 ET Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
assays on the Maurice system. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jun 10, 2025, 10:15 ET Exosome Research Market worth US$480.6 million by 2030 with 17.5% CAGR | MarketsandMarkets™
exosome research arena, showcasing a dual focus on environmental sustainability and advancements in technological efficiency. Bio-Techne (US) Bio-Techne solidified its status as a significant player in the liquid biopsy diagnostics arena following its acquisition of Exosome Diagnostics
More news about: MarketsandMarkets
Jun 10, 2025, 07:00 ET ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Jun 04, 2025, 16:24 ET IBO Releases 2024 Executive Compensation Review for Scientific Instrumentation and Lab Tools Industry
total compensation for these leaders increased 3.4% to $2.4 million. William Geist of Bio-Techne topped the list at $3.6 million. "2024 was a reset year for the scientific tools industry," said Tanya Samazan,
More news about: Instrument Business Outlook
May 29, 2025, 07:00 ET Bio-Techne to Present at Investor Conferences
https://investors.bio-techne.com/ir-calendar. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
May 15, 2025, 15:19 ET Single-Cell Genomics and Proteomics: Leading the Future of Biomedical Research
10X GENOMICSAGILENT TECHNOLOGIES INC.BDBIO-RAD LABORATORIES INC.BIO-TECHNEBRUKERF. HOFFMANN-LA ROCHE LTD.ILLUMINA INC.MERCK KGAAPROMEGA CORP.QIAGENSARTORIUS
More news about: BCC Research LLC
May 14, 2025, 07:00 ET ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
May 13, 2025, 15:05 ET Liquid Biopsy Market Boom: Tools, Services, and Diagnostics Unveiled
holds the largest share of the market. Market leaders include: Bio-Rad Laboratories Inc. Bio-TechneDxcover Ltd.Exact Sciences Corp.F. Hoffmann-La Roche Ltd.FreenomeGuardant HealthIllumina Inc.Myriad
More news about: BCC Research LLC
May 12, 2025, 07:00 ET Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
use in diagnostic procedures. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
May 08, 2025, 09:30 ET Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
www.kytopen.com Bio-TechneDavid Clair, Vice President, Investor Relations & Corporate [email protected] 612-656-4416 About Bio-Techne Bio-Techne Corporation
More news about: Kytopen
May 08, 2025, 07:00 ET Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
https://investors.bio-techne.com/ir-calendar. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
May 07, 2025, 10:30 ET Single Cell Analysis Market worth US$7.56 billion by 2030 with 14.7% CAGR | MarketsandMarkets™
Cytek Biosciences (US), Takara Bio Inc. (Japan), bioMérieux (France), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Oxford Nanopore Technologies Plc (UK), The Menarini Group (Italy),
More news about: MarketsandMarkets
May 07, 2025, 06:30 ET BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
dollar amount or number of shares of common stock. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological
More news about: Bio-Techne Corporation
May 07, 2025, 06:30 ET BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
release. "Despite a dynamic macroenvironment, the Bio-Techne team once again executed at a high level and delivered strong third quarter results," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "Our pharma end market continued to improve, especially
More news about: Bio-Techne Corporation
May 06, 2025, 07:00 ET ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
G-Rex® device at a time. About Bio-Techne Corporation Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
May 01, 2025, 15:02 ET In Vitro Diagnostics: Technologies Transforming Global Healthcare Markets
include: AbbottBecton, Dickinson and Co.BiomerieuxBio-Rad Laboratories Inc.Bio-TechneBrukerDanaher Corp.EKF Diagnostics Holdings PlcF. Hoffmann-La Roche Ltd.Hologic Inc.JSR Corp.Quidelortho
More news about: BCC Research LLC
Apr 29, 2025, 07:00 ET ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Apr 24, 2025, 07:00 ET Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
Bio-Techne's scientific team. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Apr 23, 2025, 07:00 ET Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
https://www.bio-techne.com/about/events/aacr. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations
More news about: Bio-Techne Corporation
Apr 15, 2025, 07:00 ET Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results
Saturday, June 7, 2025. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation